ETF DAILY NEWS

Brokerages Set NewAmsterdam Pharma (NASDAQ:NAMS) PT at $43.33

Shares of NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) have been given an average rating of “Buy” by the six analysts that are currently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have covered the stock in the […]

Mar 14, 2025 - 06:22
 0
Brokerages Set NewAmsterdam Pharma (NASDAQ:NAMS) PT at $43.33
Shares of NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) have been given an average rating of “Buy” by the six analysts that are currently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have covered the stock in the […]
Read More

Tags:

Previous Article

Comparing Sprott (NYSE:SII) & Integrated Ventures (OTCMKTS:INTV)

Next Article

Analysts Set First Commonwealth Financial Co. (NYSE:FCF) Price Target at $19.58

Related Posts

Galapagos (GLPG) Expected to Announce Quarterly Earnings on Friday

Galapagos (GLPG) Expected to Announce Quarterly Earning...

Feb 21, 2025  0

Principal Securities Inc. Grows Stock Position in LyondellBasell Industries (NYSE:LYB)

Principal Securities Inc. Grows Stock Position in Lyond...

Feb 22, 2025  0

SG Americas Securities LLC Sells 1,503 Shares of VanEck Junior Gold Miners ETF (NYSEARCA:GDXJ)

SG Americas Securities LLC Sells 1,503 Shares of VanEck...

Feb 10, 2025  0